6662 Stock Overview
Provides bio-materials and surgical services in Taiwan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
BioLASCO Taiwan Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$35.50 |
| 52 Week High | NT$41.00 |
| 52 Week Low | NT$31.60 |
| Beta | 0.44 |
| 11 Month Change | -2.20% |
| 3 Month Change | -2.74% |
| 1 Year Change | 11.29% |
| 33 Year Change | 15.64% |
| 5 Year Change | -7.79% |
| Change since IPO | -47.69% |
Recent News & Updates
Recent updates
We Think You Should Be Aware Of Some Concerning Factors In BioLASCO Taiwan's (GTSM:6662) Earnings
Apr 01
Are BioLASCO Taiwan Co., Ltd.'s (GTSM:6662) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 11Investors In BioLASCO Taiwan Co., Ltd. (GTSM:6662) Should Consider This, First
Feb 10
Is BioLASCO Taiwan (GTSM:6662) A Risky Investment?
Jan 08BioLASCO Taiwan Co., Ltd.'s (GTSM:6662) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Dec 10Shareholder Returns
| 6662 | TW Life Sciences | TW Market | |
|---|---|---|---|
| 7D | -1.7% | -3.6% | -4.2% |
| 1Y | 11.3% | -13.0% | 28.9% |
Return vs Industry: 6662 exceeded the TW Life Sciences industry which returned -14.4% over the past year.
Return vs Market: 6662 underperformed the TW Market which returned 30.2% over the past year.
Price Volatility
| 6662 volatility | |
|---|---|
| 6662 Average Weekly Movement | 2.8% |
| Life Sciences Industry Average Movement | 4.0% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.0% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6662 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 6662's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 87 | n/a | www.biolasco.com.tw |
BioLASCO Taiwan Co., Ltd. provides bio-materials and surgical services in Taiwan and internationally. It breeds and produces SPF laboratory rats and mice, including outbreed stocks, inbreed strains, and immune deficient models, as well as offers special animal model services. The company also provides endotoxin detection, animal heath diagnostic, and serological kits, as well as biological indicators.
BioLASCO Taiwan Co., Ltd. Fundamentals Summary
| 6662 fundamental statistics | |
|---|---|
| Market cap | NT$909.23m |
| Earnings (TTM) | NT$42.50m |
| Revenue (TTM) | NT$290.64m |
21.4x
P/E Ratio3.1x
P/S RatioIs 6662 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6662 income statement (TTM) | |
|---|---|
| Revenue | NT$290.64m |
| Cost of Revenue | NT$184.55m |
| Gross Profit | NT$106.09m |
| Other Expenses | NT$63.58m |
| Earnings | NT$42.50m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.66 |
| Gross Margin | 36.50% |
| Net Profit Margin | 14.62% |
| Debt/Equity Ratio | 24.3% |
How did 6662 perform over the long term?
See historical performance and comparison